{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:33:34Z","timestamp":1794724414884,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer US","isbn-type":[{"value":"9781071626504","type":"print"},{"value":"9781071626511","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2651-1_15","type":"book-chapter","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T14:08:04Z","timestamp":1670508484000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ophthalmic Fluorescein Angiography"],"prefix":"10.1007","author":[{"given":"Divin O.","family":"Baddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D.","family":"Ragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Kiong","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cber.18710040209","volume":"4","author":"A Baeyer","year":"1871","unstructured":"Baeyer A (1871) Uber ein neue Klasse van farbstoffen. Der Deutschen Chem Ges 4:555","journal-title":"Der Deutschen Chem Ges"},{"key":"15_CR2","doi-asserted-by":"crossref","unstructured":"Ehrlich P (1882) Uber provilirte fluoresceinzerscheinungen. Am Aug Dtsch Med Wochenschr:8\u201321","DOI":"10.1055\/s-0029-1196319"},{"key":"15_CR3","first-page":"445","volume":"48","author":"A Burke","year":"1910","unstructured":"Burke A (1910) Die klinische physiologische und pathologie bedeuting der fluorescein im auge nach darrerching von-uranin. Klin Monatsbl Augenheilkd 48:445\u2013454","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archopht.1967.00980030457009","volume":"78","author":"JDM Gass","year":"1967","unstructured":"Gass JDM, Sever RJ, Sparks D et al (1967) A combined technique of fluorescein fundoscopy and angiography of the eye. Arch Ophthalmol 78:455\u2013461","journal-title":"Arch Ophthalmol"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-68987-6","volume-title":"Retinal angiography and optical coherence tomography","author":"JF Arevalo","year":"2009","unstructured":"Arevalo JF (2009) Retinal angiography and optical coherence tomography. Springer, pp 1\u2013471"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0042-6989(80)90045-0","volume":"20","author":"MA Bloome","year":"1980","unstructured":"Bloome MA (1980) Fluorescein angiography: risks. Vis Res 20:1083\u20131097","journal-title":"Vis Res"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00004397-197701720-00005","volume":"17","author":"JS Kelley","year":"1977","unstructured":"Kelley JS (1977) Fluorescein angiography: techniques and toxicity. Int Ophthalmol Clin 17:25\u201333","journal-title":"Int Ophthalmol Clin"},{"key":"15_CR8","first-page":"465","volume":"65","author":"BJ Jennings","year":"1994","unstructured":"Jennings BJ, Mathews DE (1994) Adverse reactions during retinal fluorescein angiography. J Am Optom Assoc 65:465\u2013471","journal-title":"J Am Optom Assoc"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0161-6420(86)33697-2","volume":"93","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi LA, Rohrer KT, Tindel LJ et al (1986) Fluorescein angiography complication survey. Ophthalmology 93:611\u2013617","journal-title":"Ophthalmology"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0002-9394(14)70686-5","volume":"109","author":"LS Halperin","year":"1990","unstructured":"Halperin LS, Olk J, Soubrane G et al (1990) Safety of fluorescein angiography during pregnancy. Am J Ophthalmol 109:563\u2013566","journal-title":"Am J Ophthalmol"}],"container-title":["Methods in Molecular Biology","Retinitis Pigmentosa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2651-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T22:59:33Z","timestamp":1674255573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2651-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"ISBN":["9781071626504","9781071626511"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2651-1_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-0716-2651-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"9 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Stephen H. Tsang receives financial support from Abeona Therapeutics, Inc and Emendo. He is also the founder of Rejuvitas and is on the scientific and clinical advisory board for Nanoscope Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}